KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeMD (LFMD) Interest Expenses (2016 - 2025)

LifeMD filings provide 14 years of Interest Expenses readings, the most recent being -$190791.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 131.4% to -$190791.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 37.44% decrease, with the full-year FY2025 number at $1.4 million, down 37.44% from a year prior.
  • Interest Expenses hit -$190791.0 in Q4 2025 for LifeMD, down from $262456.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $3.0 million in Q4 2021 to a low of -$190791.0 in Q4 2025.
  • Median Interest Expenses over the past 5 years was $583129.5 (2024), compared with a mean of $664206.2.
  • Biggest five-year swings in Interest Expenses: skyrocketed 748.76% in 2021 and later plummeted 131.4% in 2025.
  • LifeMD's Interest Expenses stood at $3.0 million in 2021, then plummeted by 71.97% to $843541.0 in 2022, then decreased by 26.18% to $622685.0 in 2023, then decreased by 2.41% to $607662.0 in 2024, then tumbled by 131.4% to -$190791.0 in 2025.
  • The last three reported values for Interest Expenses were -$190791.0 (Q4 2025), $262456.0 (Q3 2025), and $663027.0 (Q2 2025) per Business Quant data.